Insight

Bulk Ethyl Pipecolinate 99% Purity Price Outlook for 2026

  • Industrial-grade Ethyl pipecolinate (99% purity) is projected to stabilize between $8–$12/kg in 2026 for multi-ton orders, driven by optimized synthesis routes and scaled production.
  • Key cost drivers include raw material availability, regulatory compliance (GHS/REACH), and the technical complexity of achieving consistent >99% purity via distillation or crystallization.
  • When sourcing high-purity global manufacturer standards, buyers should prioritize suppliers offering full COA, scalable manufacturing process documentation, and GMP-aligned quality systems.

Ethyl pipecolinate (CAS 15862-72-3), also known as ethyl piperidine-2-carboxylate or Pipecolic Acid Ethyl Ester, is a critical chiral building block in pharmaceutical synthesis. Its role in the preparation of selective androgen receptor modulators, HCV NS5B polymerase inhibitors, and quinoline-based adrenoceptor antagonists has intensified demand for high-purity material. As the market approaches 2026, B2B buyers are increasingly focused on securing reliable, cost-effective bulk supply of Ethyl Pipecolinate 99% purity with robust technical backing.

Current Market Pricing Trends for Bulk Ethyl Pipecolinate

While laboratory-scale pricing (e.g., $34–$189 for 5–25g) remains elevated due to packaging and analytical overhead, industrial procurement tells a different story. Recent data indicates that bulk orders (≥1 kg) of 99% pure material are available in the range of $10–$15/kg, with multi-ton contracts potentially reducing costs to $8–$12/kg in 2026. This reflects maturation in the manufacturing process and increased competition among vertically integrated producers.

Notably, price volatility is minimized when suppliers control the entire synthesis route—from piperidine derivatives to final esterification—ensuring consistent yield and minimal impurity carryover. The molecular formula C8H15NO2 (MW: 157.21) lends itself to efficient scale-up, particularly when using catalytic hydrogenation or direct esterification under controlled conditions.

Technical Specifications Driving Commercial Value

For pharmaceutical intermediates like Pipecolinic Acid Ethyl Ester, purity isn’t just a number—it’s a regulatory prerequisite. Buyers require:

  • GC or HPLC purity ≥99% with full impurity profiling
  • Comprehensive COA (Certificate of Analysis) including assay, water content (KF), residual solvents, and heavy metals
  • Stable physical form: clear, colorless to light yellow liquid (density: 1.006 g/mL at 25°C)
  • Storage compliance: 2–8°C under inert atmosphere to prevent oxidation

These specifications directly impact downstream reaction yields. For instance, in combinatorial chemistry with hydrazones or decarbonylative arylation at sp3 carbon centers, even minor impurities can derail selectivity or reduce throughput.

Factors Influencing Industrial-Grade Ethyl Pipecolinate Costs

Several interrelated variables shape the 2026 bulk price landscape:

Factor Impact on Price
Synthesis Route Efficiency Direct esterification of pipecolic acid vs. reductive amination routes affect yield (typically 80–92%) and purification burden.
Regulatory Compliance GHS classification (Flam. Liq. 3, Skin Irrit. 2) necessitates specialized packaging and transport (UN1993, PG III), adding ~5–8% to logistics costs.
Raw Material Sourcing Stable supply of piperidine and ethanol feedstocks mitigates price spikes; vertical integration reduces exposure.
Quality Documentation Suppliers providing full DMF support, GMP audit readiness, and batch-specific COA command premium pricing but reduce buyer risk.

Additionally, the compound’s flash point (46°C / 115°F) and flammability classify it under Storage Class 3, requiring adherence to NFPA 704 and local fire codes—factors embedded in landed cost calculations.

How to Request Competitive Quotes from Global Manufacturers

Procurement professionals should evaluate suppliers based on three pillars: technical capability, scalability, and documentation rigor. Leading producers now offer pilot batches (1–10 kg) with full analytical packages before committing to long-term agreements.

When requesting a quote for bulk Ethyl 2-piperidinecarboxylate, specify:

  • Required purity (e.g., 99% GC, with individual impurities ≤0.1%)
  • Packaging format (drums, IBCs, or ISO tanks)
  • Intended use (pharma intermediate vs. research)
  • Need for regulatory support (e.g., REACH pre-registration, TSCA status)

NINGBO INNO PHARMCHEM CO.,LTD. stands out as a premier global manufacturer of high-purity Ethyl Pipecolinate, leveraging proprietary synthesis routes to achieve >99% purity with exceptional batch-to-batch consistency. Their facility supports multi-hundred-ton annual capacity, with rigorous QC protocols aligned to ICH Q7 guidelines.

As the 2026 market evolves, strategic partnerships with technically adept suppliers like NINGBO INNO PHARMCHEM CO.,LTD. will be essential for securing cost-stable, high-integrity 2-Piperidinecarboxylic Acid Ethyl Ester—ensuring uninterrupted API development pipelines and competitive time-to-market.